Amphastar Pharmaceuticals, Inc. (AMPH)

26.71 -1.26 (-4.50%) USD  |  NASDAQ  |  Feb 26, 11:49
More

Amphastar Pharmaceuticals Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for AMPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Organon & Co. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade